Changes in Willingness to Participate in HIV Vaccine Trials Among HIV-Negative Injection Drug Users

2005 ◽  
Vol 9 (3) ◽  
pp. 301-309 ◽  
Author(s):  
Elizabeth T. Golub ◽  
Lisa A. Purvis ◽  
Marcella Sapun ◽  
Mahboobeh Safaeian ◽  
Chris Beyrer ◽  
...  
Vaccine ◽  
2008 ◽  
Vol 26 (6) ◽  
pp. 762-768 ◽  
Author(s):  
Lu Yin ◽  
Yuanzhi Zhang ◽  
Han-Zhu Qian ◽  
Baoling Rui ◽  
Lijiang Zhang ◽  
...  

Vaccine ◽  
2010 ◽  
Vol 28 (7) ◽  
pp. 1663-1667 ◽  
Author(s):  
Shayesta Dhalla ◽  
Gary Poole ◽  
Joel Singer ◽  
David M. Patrick ◽  
Evan Wood ◽  
...  

2012 ◽  
Vol 17 (2) ◽  
pp. 223-234 ◽  
Author(s):  
Shayesta Dhalla ◽  
Gary Poole ◽  
Joel Singer ◽  
David M. Patrick ◽  
Thomas Kerr

2005 ◽  
Vol 16 (4) ◽  
pp. 314-317 ◽  
Author(s):  
Paul Van de Ven ◽  
Limin Mao ◽  
June Crawford ◽  
Garrett Prestage ◽  
Andrew Grulich ◽  
...  

This study aimed to determine and describe HIV-negative gay men's willingness to participate in HIV vaccine trials. Data were from participants who completed face-to-face interviews during the first 18 months (to the end of 2002) of recruitment into the Health in Men cohort of HIV-negative gay men in Sydney. A key outcome measure was a scale of Willingness to Participate in HIV Vaccine Trials, with scores ranging from 1 (unwilling) to 4 (willing). The 903 participants ranged in age from 18 to 75years (median=36). Mean of Willingness to Participate in HIV Vaccine Trials was 2.53 (standard deviation=0.54), with approximately 51% of the men having a score greater than the midpoint of 2.50. A reduced linear regression model yielded four significant independent associations with Willingness to Participate in HIV Vaccine Trials: lack of tertiary education ( P <0.001),having engaged 'in the previous six months' in any unprotected anal intercourse with casual or non-concordant regular partners ( P <0.001), higher self-rated likelihood of HIV infection ( P <0.01), and higher mean scores on a scale of Comfort with Participation in HIV VaccineTrials ( P <0.001). The willingness of HIV-negative gay men at potentially higher risk for HIV to participate in HIV vaccine trials augurs well for enrolment in HIV vaccine efficacy trials. Recruitment into trials is likely to be enhanced by addressing salient concerns such as confidentiality and vaccine-induced antibody positivity. Also, it will be important to ensure that gay men are educated and fully informed about HIV vaccines and trial processes.


2006 ◽  
Vol 17 (3) ◽  
pp. 176-179 ◽  
Author(s):  
J Smit ◽  
K Middelkoop ◽  
L Myer ◽  
S Seedat ◽  
L-G Bekker ◽  
...  

Research on willingness to participate in HIV vaccine trials is important in preparations for HIV vaccine research, but there are few data from sub-Saharan Africa. We interviewed 198 individuals in a peri-urban South African community immediately after enrolment into an HIV vaccine preparedness study on their willingness to participate in hypothetical vaccine trials. Overall 23% of participants ( n = 46) said that they would be willing to participate in an HIV vaccine trial. Willingness was associated with increasing age, male gender, and increasing knowledge about vaccines generally and HIV vaccines specifically. In multivariate analysis, a 1-unit increase in HIV vaccine knowledge score was associated with a 10-fold increase in willingness to participate (adjusted odds ratio, 10.72, 95% confidence intervals: 4.40–26.12). These results suggest that while willingness to participate in HIV vaccine trials is relatively low in this setting, educational campaigns may have a substantial impact on individuals' willingness to participate in research.


2005 ◽  
Vol 120 (2) ◽  
pp. 150-156 ◽  
Author(s):  
Evan Wood ◽  
Kathy Li ◽  
Will Small ◽  
Julio S. Montaner ◽  
Martin T. Schechter ◽  
...  

Objectives. Few prospective studies are available on the relationship between incarceration and HIV risk among injection drug users (IDUs). The authors evaluated self-reported rates of syringe sharing and incarceration among a cohort of IDUs. Methods. This study analyzed syringe lending by HIV-infected IDUs and syringe borrowing by HIV-negative IDUs among participants enrolled in the Vancouver Injection Drug Users Study (VIDUS). Since serial measures for each individual were available, variables potentially associated with each outcome (syringe lending and borrowing) were evaluated using generalized estimating equations for binary outcomes. Results. The study sample consisted of 1,475 IDUs who were enrolled into the VIDUS cohort from May 1996 through May 2002. At baseline, 1,123 (76%) reported a history of incarceration since they first began injecting drugs. Of these individuals, 351 (31%) reported at baseline that they had injected drugs while incarcerated. Among 318 baseline HIV-infected IDUs, having been incarcerated in the six months prior to each interview remained independently associated with syringe lending during the same period (adjusted odds ratio [OR] = 1.33; 95% confidence interval [CI] 1.06, 1.69; p=0.015). Similarly, among the 1,157 baseline HIV-negative IDUs, having been incarcerated in the six months prior to each interview remained independently associated with reporting syringe borrowing during the same period (adjusted OR=1.26; 95% CI 1.12, 1.44; p<0.001). Conclusions. Incarceration was independently associated with risky needle sharing for HIV-infected and HIV-negative IDUs. This evidence of HIV risk behavior should reinforce public health concerns about the high rates of incarceration among IDUs.


2005 ◽  
Vol 37 (Supplement) ◽  
pp. S322
Author(s):  
Ellen Smit ◽  
Carlos J. Crespo ◽  
Richard D. Semba ◽  
David Jaworowicz ◽  
David Vlahov ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document